It has been suggested that EGB761 could prevent the inhibition of 4EBP1 by maintaining the mTOR signaling pathway to sustain translation initiation, thereby mitigating the effect of CCH. Here, EIF4EBP1 is linked to columnar cell hyperplasia of the breast.